It's the "factory reset" I needed.
CEO Andrew Robbins outlined the company’s transition into a pre-commercial stage at an annual healthcare conference, highlighting positive pivotal readouts for its lead candidate bezuclastinib and ...
Cullinan Therapeutics (NASDAQ:CGEM) outlined a milestone-heavy roadmap during a presentation at Leerink Partners’ Annual ...